2017-19 Strategic Plan
See the key areas the IFOPA plans to focus on over the next three years
Kim Shields is Determined to “Keep Going”
Defying Limitations, Kim Shields Encourages FOP’ers to “Keep Going”
Grantee Profile
The IFOPA and FOP Friends® UK Fund New Research at University of Oxford
Regeneron Shares Updates on its Ongoing FOP Research Program
Potentially Promising Treatment for FOP
We are pleased to share a few exciting updates on our ongoing work to help improve the lives of people with FOP.
Generous Matching Gift
Special Matching Gift Opportunity for Year-End IFOPA Supporters
Bipartisan Support
21st Century Cures Legislation Signed by President Obama
On December 7, the Senate followed the House of Representative's lead and signed the 21st Century Cures bill which is focused on developing treatments and cures for rare diseases; President Obama signed it on December 13.
Three new Clementia sites now open for Part B of the Phase 2 Open-label Extension Trial
Approval of 3 New Sites!
The participation of individuals living with FOP in clinical studies and trials is key to FOP drug development efforts.